⋆⁺₊ Alba ࿐ iteotwawki
LightNews LightNews
banner
albadocherty.bsky.social
⋆⁺₊ Alba ࿐ iteotwawki
@albadocherty.bsky.social
690 followers 360 following 1.1K posts
Every violation of truth is not only a sort of suicide in the liar, but is a stab at the health of human society. -Ralph Waldo Emerson
Posts Replies Media Videos
albadocherty.bsky.social
Another disappointing waste of Long Covid resources and time with irrelevant, if not totally misleading, findings.

onlinelibrary.wiley.com/doi/10.1002...
November 11, 2025 at 4:24 PM
albadocherty.bsky.social
between these "biomarker" levels & functional or cognitive impacts or status.

Are Pretorius & Co so incompetent as to have not done this (twice, now, re microclots)? Or did they just cherry-pick findings in effort to avoid disclosing tft these alleged biomarkers are not causitive or correalative?
November 11, 2025 at 4:24 PM
albadocherty.bsky.social
Pretorius says these NETs & microclots are "contributing causally to the LC syndrome", but her team has never been able to demonstrate that these relate to Long Covid symptoms in any manner.

Pretorius fails to show these "biomarker" levels stratified by symptom severity, there are no correlations
November 11, 2025 at 4:24 PM
albadocherty.bsky.social
Pretorius critically fails to compare the microclots & NETs of their Long Covid cohort (note: said cohort is beyond biased & questionable) to those that exist in other conditions.

These results do not ID or Dx Long Covid as they claim, as such results can indicate nearly *any inflammatory state.
November 11, 2025 at 4:24 PM
albadocherty.bsky.social
The End.
Thursday, August 14, 2025 Departure 12:00–11:59 PM
August 10, 2025 at 4:52 PM
albadocherty.bsky.social
Coffee Available 4:30–5:00 PM Concourse Clinical and Translational Approaches in PAIS 5:00–6:15 PM Eldorado Ballroom * E. Wesley Ely, Vanderbilt University Medical Center Reverse-LC Baricitinib Trial for Long COVID Amitava Banerjee, University College London Insights from STIMULATE-ICP Giulia Unali, Boston University Short Talk: Bone Marrow Hematopoietic Impairment in a Humanized Mouse Model of Post-acute Sequelae of COVID-19 Meeting Wrap-Up: Outcomes and Future Directions 6:15–6:30 PM Eldorado Ballroom Social Hour with Dinner 6:30–7:30 PM Anasazi Ballroom Poster Session 3 7:30–10:00 PM Eldorado Ballroom
August 10, 2025 at 4:52 PM
albadocherty.bsky.social
Wednesday, August 13, 2025 Breakfast 7:00–8:00 AM Anasazi Ballroom Neurological and Vascular Damages in Long COVID 8:00–11:00 AM Eldorado Ballroom Petter Brodin, Karolinska Institutet Viral Persistence and Regulation of Immunity in PACS * Avindra Nath, NINDS, National Institutes of Health Neurological Complications in Long COVID and ME CFS Jennifer Frontera, New York University Neurodegenerative Diseases Following COVID-19 Joga R. Chaganti, Thomas Jefferson University Hospital Imaging Correlates of Dysfunction in Glymphatic System, Blood Brian Barrier and Explore Glutamatergic Excitotoxicity in Long Covid Lindsay McAlpine, Yale University School of Medicine Short Talk: Cerebrospinal Fluid Alterations & Proteomics in Neuropsychiatric Long COVID Alba Azola, Johns Hopkins School of Medicine Short Talk: Blood-Brain Barrier Disruption in Long COVID and Cognitive Correlates
August 10, 2025 at 4:52 PM
albadocherty.bsky.social
Gut, Sex and other Influences on the Manifestation of PAIS 5:00–7:00 PM Eldorado Ballroom Sabra L. Klein, Johns Hopkins University Remote Presentation: Sex Differences in Long COVID Revealed by Animal Models * Maayan Levy, Stanford University The Role of Persistent Gut Infection in Long COVID Vivian Vasconcelos C Litwinski, Federal University of Minas Gerais After the Virus: Mechanisms Driving Post-Viral Sequelae Brian H LaFranchi, UCSF Short Talk: Deep Multi-Omic Analysis of Colorectal Tissues from People with and Without Long COVID Demonstrates SARS-CoV-2 Persistence and Immune Dysregulation Years After Initial Infection James Chung, University of Missouri Short Talk: Facilitating Mouse Studies of Long COVID Social Hour with Dinner 7:00–8:00 PM Anasazi Ballroom Poster Session 2 7:30–10:00 PM Anasazi Ballroom
August 10, 2025 at 4:52 PM
albadocherty.bsky.social
Panel Discussion: Long COVID: Mechanisms, Diagnosis, and Emerging Treatments 3:00–4:30 PM Eldorado Ballroom * Maggie Bartlett, Global Virus Network & Johns Hopkins School of Public Health Moderator * Sten H. Vermund, University of South Florida Moderator Akiko Iwasaki, Yale University/HHMI Anders G. Vahlne, Karolinska Institutet Resia Pretorius, Stellenbosch University Janet M Mullington, BIDMC & Harvard Medical School Annukka A Antar, Johns Hopkins School of Medicine
August 10, 2025 at 4:52 PM
albadocherty.bsky.social
What would one of these events be without them patting each other on the back and the most important thing of all: career building.
Award Recipient Acknowledgement 9:20–9:25 AM Eldorado Ballroom Poster Setup 10:30–1:00 PM Anasazi Ballroom On Own for Lunch 10:30–3:00 PM Poster Viewing 1:00–10:00 PM Anasazi Ballroom Career Roundtable 1:45–2:45 PM Eldorado Ballroom Roshan Kumar, HiFiBiO Therapeutics Executive Director, Head of Research and External Innovation Vidhya Vijayakumar, Draper Labs Principal Member of Technical Staff Annukka A Antar, Johns Hopkins School of Medicine Assistant Professor
August 10, 2025 at 4:52 PM
albadocherty.bsky.social
Post-Acute Infection Syndromes 8:00–10:30 AM Eldorado Ballroom Lisa F.P. Ng, Infectious Diseases Labs, ASTAR Post-Chikungunya Virus Autoimmune Syndrome * Michal Caspi Tal, Massachusetts Institute of Technology Unraveling the Immunopathology of Borrelia Infection-Associated Chronic Illnesses: Sex Differences and Predictive Diagnostics Maureen R. Hanson, Cornell University Immune Signaling in ME/CFS Jalene Velazquez, Washington State University Short Talk: Distinct Antibody Effector Profiles Track with the Development of Post-Ebola Syndrome Maia M Madison, UCSF Short Talk: Cytokine Biomarkers for Differential Diagnosis of Persistent Lyme Disease and Other Infection-Associated Chronic Illnesses
August 10, 2025 at 4:52 PM
albadocherty.bsky.social
Immunological Dysfunction and Mechanisms of Long COVID 5:00–7:00 PM Eldorado Ballroom * Daniel M. Altmann, Imperial College London Immune Signatures of Long COVID E. John Wherry, University of Pennsylvania Using T Cells as Biosensors in Long COVID Akiko Iwasaki, Yale University/HHMI Immunological Mechanisms of Long COVID August Jernbom, KTH Royal Institute of Technology / Johns Hopkins University Short Talk: Prevalent and Persistent New-Onset Autoantibodies in Mild to Severe COVID-19 Shubha Talwar, Imperial College London Short Talk: Investigating the Role of Autoantibodies in Long-Lasting Respiratory Symptoms Post-COVID-19
August 10, 2025 at 4:52 PM
albadocherty.bsky.social
2:15–4:30 PM An In Vitro Model for Long-COVID Using Skeletal Muscle Cultures and Patient Plasma * Timothy J. Henrich, University of California, San Francisco Multi-Omic Analysis of Bone Marrow from People with and Without Long COVID Reveals Lymphoproliferative Disorders and Immune Dysregulation but Not SARS-CoV-2 Persistence Penelope Markham, BioVie A Phase 2 Trial Designed to Enhance Signal Detection in an Evaluation of Bezisterim (NE3107) For the Treatment of Neurological Symptoms of Long COVID Claire S Laxton, Yale University Development of a Multiplex qPCR To Detect Herpesvirus Reactivation and Shedding Dynamics in Saliva of Long Covid Patients Emma Wall, The Francis Crick Institute An Innate Inflammatory Signature Is Consistently Enriched in the Plasma of Adults Living with Long COVID Across all Clinical Symptom Groups Nadia R. Roan, University of California, San Francisco Inhibition of CXCR4 Signaling Reverses Behavioral Abnormalities in a Mouse Model of Long COVID Est
August 10, 2025 at 4:52 PM
albadocherty.bsky.social
Career building blah blah blahhhh
Coffee Break 9:30–9:50 AM Concourse Lunch 11:15–12:15 PM Anasazi Ballroom Women in Science Networking Session 11:20–12:15 PM Eldorado Ballroom * Emma Wall, The Francis Crick Institute * Nadia R. Roan, University of California, San Francisco * Esther Melamed, Dell Medical School * Hanna Ollila, University of Helsinki and Harvard University * Courtney Malo, Science Translational Medicine Poster Session 1 11:45–2:15 PM Anasazi Ballroom
August 10, 2025 at 4:52 PM
albadocherty.bsky.social
Schedule
Welcome and Keynote Address 8:00–9:00 AM Eldorado Ballroom * Akiko Iwasaki, Yale University/HHMI * Hannah Davis, Patient-Led Research Collaborative Michael J Peluso, University of California, San Francisco Long COVID: What We have Learned so far and What Needs to Happen Next Epidemiology, Clinical Diagnosis and Management of Long COVID 9:00–11:15 AM Eldorado Ballroom * Hannah Davis, Patient-Led Research Collaborative Two patterns in Long Covid: Craniocervical Instability and Illness Duration Ziyad Al-Aly, Washington University School of Medicine Epidemiology of Long COVID David Putrino, Mount Sinai School of Medicine Clinical Diagnosis and Management of Long COVID Michelle J L Scoullar, Burnet Institute Short Talk: A Narrative Review of the Impact, Treatment and Outcomes of Paediatric Long COVID, Including the Prevalence of Dysautonomia, From A Specialist Long COVID Clinic in Australia
August 10, 2025 at 4:52 PM
albadocherty.bsky.social
Sponsors
August 10, 2025 at 4:52 PM
albadocherty.bsky.social
"Lower risk of dementia with AS01-adjuvanted vaccination against shingles and respiratory syncytial virus infections" JUN 2025

www.nature.com/articles/s4...
Lower risk of dementia with AS01-adjuvanted vaccination against shingles and respiratory syncytial virus infections
npj Vaccines - Lower risk of dementia with AS01-adjuvanted vaccination against shingles and respiratory syncytial virus infections
www.nature.com
July 21, 2025 at 1:48 PM
albadocherty.bsky.social
The vaccines noted in the study are mfg by:

Shingrix AS01-adjuvanted shingles vax: by GSK
Arexvy AS01-adjuvanted RSV vax: by GSK
Zostavax live shingles vax (now discontinued): by Merck
Abrysvo RSV vax w/o AS01: by Pfizer

None of which are reported to have funded this study.
July 21, 2025 at 1:48 PM
albadocherty.bsky.social
"The characteristic change of autoimmune encephalitis after the COVID-19 epidemic in Guangxi, China"

* 126 patients were infected with COVID-19
* 13 patients experienced relapse during follow-up (12 with Covid, 1 without)

nature.com/articles/s4...
The characteristic change of autoimmune encephalitis after the COVID-19 epidemic in Guangxi, China
Scientific Reports - The characteristic change of autoimmune encephalitis after the COVID-19 epidemic in Guangxi, China
www.nature.com
July 21, 2025 at 1:32 PM